CVS Health Corporation
CVS
$67.09
-$0.76-1.12%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.78B | 1.64B | 87.00M | 1.77B | 1.11B |
| Total Depreciation and Amortization | 1.15B | 1.15B | 1.16B | 1.15B | 1.14B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.00M | -537.00M | 386.00M | 7.00M | -69.00M |
| Change in Net Operating Assets | 1.43B | -394.00M | -2.38B | 161.00M | 2.72B |
| Cash from Operations | 4.56B | 1.86B | -745.00M | 3.09B | 4.90B |
| Capital Expenditure | -743.00M | -768.00M | -670.00M | -638.00M | -705.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -20.00M | -10.00M | -12.00M | -48.00M | -25.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00M | 231.00M | -2.67B | -939.00M | -1.36B |
| Cash from Investing | -762.00M | -547.00M | -3.35B | -1.63B | -2.09B |
| Total Debt Issued | -- | 4.27B | 600.00M | 2.44B | 2.52B |
| Total Debt Repaid | -1.60B | -3.07B | -1.47B | -219.00M | -18.00M |
| Issuance of Common Stock | 144.00M | 19.00M | 114.00M | 25.00M | 203.00M |
| Repurchase of Common Stock | -11.00M | -4.00M | -4.00M | -142.00M | -3.06B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -840.00M | -838.00M | -837.00M | -858.00M | -840.00M |
| Other Financing Activities | -23.00M | 48.00M | 8.00M | 3.00M | -33.00M |
| Cash from Financing | -2.33B | 431.00M | -1.59B | 1.25B | -1.23B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.46B | 1.74B | -5.68B | 2.71B | 1.58B |